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Abstract The normal infundibulum and neurohypophysis
consist entirely of neuronal processes, the neuronal cell
bodies of which lie within the supraoptic and paraven-
tricular nuclei of the hypothalamus and supportive glial
cells or pituicytes. The finding of neurons within the
neurohypophysis is exceedingly rare, as are ganglion cell
tumors at this site. In this paper, we report a ganglion cell
tumor of the neurohypophysis found incidentally at
autopsy. Despite chronic hypertension and the finding of
some vasopressin immunoreactivity in lesional neurons, the
syndrome of inappropriate antidiuretic hormone secretion
(SIADH) was excluded on the basis of normal serum
sodium levels. The morphologic and immunohistochemical
features of the tumor are presented, cytogenetic consider-
ations are discussed, and literature regarding neuronal
lesions of the pituitary gland is reviewed.
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Introduction
Neurohypophysial lesions are rare. Most consist of inflam-
matory processes, some related to adenohypophysitis [1].
Neoplasms are rare and consist primarily of glial lesions
originating in modified astrocytes of the posterior lobe also
termed pituicytes. Such cells presumably give rise to both
granular cell tumor [2] and to pituicytoma, a recently
characterized tumor [3] distinct from pilocytic astrocytoma,
a much more common lesion of the hypothalamus [4].
Neuronal lesions are exceedingly rare. They include one
report of neuronal ectopia [5], a lesion less cellular and
tumefactive than gangliocytoma, and one example of a
symptomatic, vasopressin (antidiuretic hormone)-producing
ganglioglioma associated with syndrome of inappropriate
antidiuretic hormone secretion (SIADH) [6]. Herein, we
report a nonvasopressin-producing neurohypophysial gan-
glion cell tumor, an incidental autopsy finding. Although
associated with hypertension, no evidence of SIADH was
apparent on laboratory examination.
Clinical History
The patient was an 89-year-old female with early dementia
consistent with Alzheimer’s disease, systemic arterial
hypertension and an 8-year history of chronic lung disease
consistent with usual interstitial pneumonia. She was
recently discharged from the hospital for a hip fracture
and, shortly thereafter, developed pneumonia. Despite anti-
biotic and prednisone therapy as well as BiPAP ventilation,
she showed no improvement. An echocardiogram revealed
severe bi-atrial dilation, aortic valve regurgitation, and left
ventricular diastolic dysfunction and hypertrophy. Death
was attributed to acute respiratory failure.
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Pathology
The 1,260-gram brain showed mild generalized and
moderate temporal lobe atrophy corresponding to moderate
to marked (Braak & Braak stages IV–V) neurodegenerative
changes of Alzheimer type in association with mild-to-
moderate amyloid angiopathy. Microsections of the neo-
cortex and mesial temporal lobe structures disclosed
moderate diffuse plaques, sparse to moderate neuritic
plaques and absent (calcarine) to moderate neurofibrillary
tangle and thread formation. Mild cranial arterial athero-
sclerosis was also noted. Grossly, coronal sections through-
out the anteroposterior extent of the hypothalamus appeared
normal. Despite lack of gross abnormalities of the pitu-
itary, horizontally cut microsections revealed mild, asym-
metric enlargement of the posterior lobe because of a
bilobed infiltrate (Fig. 1A), one ill-defined and the other
more discrete, consisting of mature neurons and a very
minor component of astrocytes. The appearance was that
of a ganglion cell tumor (ganglioglioma). The neurons
included dysmorphic and occasional binucleate examples
(Fig. 1B), some showing marked cytoplasmic neurofibril-
lary tangle formation (Fig. 1C). No inflammatory infiltrate
was noted within the lesion. Basophil invasion, moderate in
extent, was partially displaced and partly infiltrated by the
tumor, the neurons being intimately associated with the
basophils (Fig. 1D). The pituitary stalk and adenohypoph-
ysis were normal and uninvolved by tumor. Immunostains
(streptavidin–biotin peroxidase complex method) for pitu-
itary hormones showed only normal reactivities within
the adenohypophysis, but no staining within the tumor.
The accompanying basophil invasion showed staining for
adrenocorticotropic hormone (ACTH) and endorphin.
Immunostains for chromogranin (Fig. 2A) (Dako, Car-
pinteria, CA; 1:800, 2F11) were positive in ganglion cells,
whereas the vasopressin (Sera, West Sussex; 1:500, AE8
Fig. 1 Microsections of the expanded asymmetric posterior lobe show accumulation of ganglion cells and scant astrocytes (A). Ganglion cells are
dysmorphic (B), and feature neurofibrillary tangles (C). Note association of ganglion cells with basophil invasion (D)
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321) reaction was negative. Reactivity within residual
neurohypophyseal tissue also included neurophysin
(Dako, 1:1000, polyclonal). Tau protein immunoreactivity
(Endogen, Woburn, MA; 1:3750, AT8) was strong within
tangle-bearing neurons (Fig. 2B) and threads. No Pick
bodies were noted. Alpha synuclein stains were negative.
Microsections through the paraventricular and supraoptic
nuclei showed all but one, a markedly gliotic paraven-
tricular nucleus, to be histologically normal.
Discussion
The neurohypophysis consists of: (a) axons of magnocel-
lular neurons comprising the supra-optic and paraventricu-
lar nuclei of the hypothalamus, (b) functionally specialized
astrocytes termed “pituicytes” [7], and (c) fenestrated
capillaries at which the hormones vasopressin and oxytocin
as well as their respective neurophysins are released into
the circulation. When compared to the adenohypophysis
with its high frequency of pituitary adenomas, 20% in one
autopsy series [8], neurohypophysial tumors are rare. They
include primarily granular cell tumors [2] and the very
infrequent pituicytoma [3], both derived from pituicytes,
functionally specialized, osmotically reactive astrocytes of
the posterior lobe.
A number of pituitary and sellar region lesions are
neuronal in nature. These include: (a) hypothalamic
neuronal hamartoma, some of which are endocrine-active
by way of producing releasing hormone [9], and (b)
gangliocytoma of the sella, either in isolation [10, 11] or
in association with a pituitary adenoma [10, 12]. Both of
the above are rare. Of gangliocytomas of the sella, entirely
65% are adenoma-associated, and 75% are endocrine-active
[12]. The genesis of those in which a pituitary adenoma,
typically a growth hormone and only rarely an adrenocor-
ticotropin [13–15] or prolactin-producing adenoma [16–
18], have invited two very different pathophysiologic
explanations. One mechanism, the earliest proposed, sug-
gested that the neuronal lesions, by producing hypothalam-
ic releasing hormones, result in pituitary hyperplasia and
promote adenomagenesis [12]. Multiple reports invoked
this explanation [11, 13, 19], and the concept still has its
adherents [20]. Demonstration of both the releasing
hormone in the gangliocytomas and the respective pituitary
hormone in the adenoma lends it support. Of particular
interest is one case in which a hypothalamic and sellar
gangliocytoma-producing enkephalin was associated with a
prolactinoma [16]; enkephalin is known to have a stimu-
lating effect on prolactin cells. On the other hand, several
observations support an alternative, very different view, which
is that adenoma cells undergo neuronal metaplasia, the
resultant lesion being termed “pituitary adenoma-neuronal
choristoma” (PANCH) [21]. Such transformation has been
documented by morphologic, immunohistochemical, and
ultrastructural methods [21]. A number of observations lend
insight into this mechanism and support its occurrence,
including: (a) lack of pituitary hyperplasia as an element
of PANCH [21], (b) the almost exclusive GH-producing
adenoma subtype involved, (c) transition to adenoma cells
being minute and multifocal in some adenomas, and (d)
the fact that a subset of pituitary adenomas of acromegaly
produce growth hormone-releasing hormone [22], its
stimulatory effect apparently being autocrine. In contrast,
the posterior pituitary is rarely affected by neuronal
lesions; only four cases have been reported in humans
[5, 6, 10, 23]. One previous example of ectopic ganglion
cells, perhaps an example of a gangliocytoma was re-
ported by Horvath et al [5]. It was an incidental autopsy
finding in an 80-year-old female with no evidence of
endocrinopathy. The neurons resembled magnocellular
hypothalamic neurons, were α-SU and β-endorphin
immunoreactive, and were intimately associated with
Fig. 2 Immunohistochemical features include reactivity of ganglion
cells for chromogranin (A) and tau protein (B)
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basophil invasion. No vasopressin staining was noted.
Etiologic considerations included: (a) an ectopia, possibly
the result of a migration abnormality, (b) maturation of
neuroblasts presumed to occur in the embryonic neurohy-
pophysis, and lastly, (c) neuronal “transdifferentiation”
from the ACTH-positive cells of basophil invasion. A
second published neuronal lesion of the neurohypophysis
was a ganglioglioma like our own [6]. Its key feature was
its occurrence in association with the syndrome of in-
appropriate antidiuretic hormone (ADH) secretion and the
finding of vasopressin within its neurons. This rare lesion
expanded the spectrum of processes underlying this syn-
drome, which includes vasopressin production by malignant
tumors at ectopic sites, as well as head trauma, infection,
drugs, and pituitary stalk compression. Yet another posterior
lobe ganglion cell lesion has recently been reported [10]. It
occurred in a 54-year-old man with Cushing syndrome
and positive inferior petrosal sinus sampling for ACTH. The
1-cm lesion was removed transsphenoidally and consisted
entirely of posterior pituitary tissue containing normal-
appearing, small ganglion cells in association with a basophil
invasion. The ganglion cells were immunonegative for
ACTH and corticotropin-releasing hormone. After the
operation, Cushing syndrome abated. Also of interest is a
long-standing neuronal lesion of the sella associated with
hyperprolactinemia, but no adenoma [23]. This tumor was
termed “differentiating neuroblastoma” due to its partial
composition of immature neurons. The tumor adds to the
already complex classification of neuronal sellar lesions in
that its ultrastructurally biphasic cell composition included:
(a) a neuroblastic and gangliocytic element showing some
oxytocin and perhaps prolactin immunoreactivity, in
addition to (b) cells compatible with adenohypophysial
epithelium, and (c) transitional forms. On an interesting
note, a gangliocytoma with an immature neuronal com-
ponent occurring in the pituitary of a rat has also been
recently described [24]. The lesion consisted of mature,
small immature, and transitional cells and exhibited oc-
casional mitotic figures. Lastly, reference is also made to a
“mature ganglioneuroma” in the pituitary of a Fischer rat
[25].
Of tangential interest is the finding in our case of
conspicuous neurodegenerative changes. These have been
described in isolated cases of ganglion cell tumor [26, 27]
and were recently the subject of a systematic study of 72
examples involving the brain, including 61 gangliogliomas
and 11 gangliocytomas in patients of various ages [28].
Abnormalities related to tau protein (neurofibrillary tangles,
neuropil threads, Pick bodies) and granulovacuolar degen-
eration were noted in approximately 10%, being much
more common in older patients but unrelated to the Apo E
genotype, a factor predisposing to Alzheimer disease.
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